Outbound Relationships |
Type |
Target |
Active |
Characteristic |
Refinability |
Group |
Values |
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Ergotamine product |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Product containing ergotamine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Product containing ergotamine tartrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ergotamine tartrate (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Caffeine + ergotamine tartrate |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Stimulant (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Bronchodilator |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Caffeine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Phosphodiesterase inhibitor |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Product containing caffeine and ergotamine (medicinal product) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Xanthine |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Analgesic (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has manufactured dose form |
Rectal dose form (dose form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Product containing caffeine in rectal dose form (medicinal product form) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has manufactured dose form |
Rectal suppository |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
Ergotamine (substance) |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength denominator unit (attribute) |
Suppository (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has unit of presentation |
Suppository (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength numerator unit (attribute) |
mg |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength denominator unit (attribute) |
Suppository (unit of presentation) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength denominator value |
un |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength numerator value |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has basis of strength substance (attribute) |
Caffeine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has precise active ingredient |
Caffeine |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has basis of strength substance (attribute) |
Ergotamine tartrate (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has precise active ingredient |
Ergotamine tartrate (substance) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
2 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Has presentation strength numerator value |
10^2 |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
1 |
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Count of base of active ingredient |
deux |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Is a |
Product containing only caffeine and ergotamine in rectal dose form (medicinal product form) |
true |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|
Ergotamine tartrate+caffeine 2mg/100mg suppository (substance) |
Plays role |
Antimigraine therapeutic role |
false |
Inferred relationship |
Existential restriction modifier (core metadata concept) |
|
|